PhaseRx Inc (PZRX)-医療機器分野:企業M&A・提携分析

◆英語タイトル:PhaseRx Inc (PZRX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011291
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PhaseRx Inc (PhaseRx), formerly PhaseRx Pharmaceuticals Inc is a healthcare products provider that conducts research and develops RNA nanomedicines for the treatment of orphan diseases. The company discovers and develops drugs based on SMARTT polymer technology, which offers mRNA delivery techniques. Its products under clinical development include PRX-OTC, PRX-ASL and argininosuccinatesynthetase. PhaseRx’s SMARTT polymer technology provides platform for the development of RNA-based drugs. The company offers products for the treatment of inherited metabolic disease and liver cancer. It has research collaborations with pharmaceutical and biotechnology companies. PhaseRx is headquartered in Seattle, Washington, the US.

PhaseRx Inc (PZRX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PhaseRx Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
PhaseRx Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
PhaseRx Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
PhaseRx Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
PhaseRx Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
PhaseRx Inc, Medical Equipment, Deal Details 10
Equity Offering 10
PhaseRx Plans to Raise up to USD15 Million in Public Offering of Shares and Warrants 10
PhaseRx Raises Funds through Pivate Placement of Shares up on Exercise of Warrants 11
Debt Offering 12
PhaseRx Raises USD1.2 Million in Private Placement of Notes 12
PhaseRx Raises USD0.8 Million in Private Placement of Notes 13
PhaseRx Inc – Key Competitors 14
PhaseRx Inc – Key Employees 15
PhaseRx Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Nov 09, 2017: PhaseRx Reports Third Quarter 2017 Financial Results and Provides Corporate Update 17
Aug 10, 2017: PhaseRx Reports Second Quarter 2017 Financial Results and Provides Corporate Update 18
May 12, 2017: PhaseRx Reports First Quarter 2017 Financial Results and Provides Corporate Update 19
Mar 27, 2017: PhaseRx Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update 20
Nov 07, 2016: PhaseRx Reports Third Quarter 2016 Financial Results and Provides Corporate Update 21
Aug 02, 2016: PhaseRx Reports Second Quarter 2016 Financial Results and Provides Corporate Update 22
Corporate Communications 23
Aug 22, 2016: PhaseRx Appoints Peggy Phillips to Board of Directors 23
Jul 20, 2016: PhaseRx Appoints Gordon Brandt, M.D. as Chief Medical Officer 24
Feb 09, 2016: PhaseRx Strengthens Board of Directors and Leadership Team 25
Legal and Regulatory 26
Dec 13, 2017: PhaseRx Receives Decision from the Nasdaq Hearings Panel for Continued Listing of Shares 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
PhaseRx Inc, Medical Equipment, Key Facts, 2016 2
PhaseRx Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
PhaseRx Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
PhaseRx Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
PhaseRx Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
PhaseRx Inc, Deals By Market, 2011 to YTD 2017 8
PhaseRx Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
PhaseRx Plans to Raise up to USD15 Million in Public Offering of Shares and Warrants 10
PhaseRx Raises Funds through Pivate Placement of Shares up on Exercise of Warrants 11
PhaseRx Raises USD1.2 Million in Private Placement of Notes 12
PhaseRx Raises USD0.8 Million in Private Placement of Notes 13
PhaseRx Inc, Key Competitors 14
PhaseRx Inc, Key Employees 15
PhaseRx Inc, Subsidiaries 16

★海外企業調査レポート[PhaseRx Inc (PZRX)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Unitika Ltd (3103):企業の財務・戦略的SWOT分析
    Unitika Ltd (3103) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Bone Therapeutics SA (BOTHE):製薬・医療:M&Aディール及び事業提携情報
    Summary Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. The company offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for the treatment of osteonecrosis and non-union fracture …
  • Reply SpA (REY):企業の財務・戦略的SWOT分析
    Reply SpA (REY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Huons Global Co Ltd (084110):企業の財務・戦略的SWOT分析
    Huons Global Co Ltd (084110) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Dampier Gold Limited:企業の戦略・SWOT・財務分析
    Dampier Gold Limited - Strategy, SWOT and Corporate Finance Report Summary Dampier Gold Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ypsomed Holding AG (YPSN)
    Ypsomed Holding AG (YPSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Magellan Midstream Partners LP (MMP):企業の財務・戦略的SWOT分析
    Magellan Midstream Partners LP (MMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Yumanity Therapeutics Inc (YMTX):企業の財務・戦略的SWOT分析
    Yumanity Therapeutics Inc (YMTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • ENAMINE Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Enamine Ltd (Enamine) is a provider of screening and drug discovery services. The company’s products include building blocks and intermediates, screening compounds, real database, compound libraries, fragment library, tangible building blocks, materials chemistry and scaffolds. It offers ser …
  • Antibe Therapeutics Inc (ATE)-製薬・医療分野:企業M&A・提携分析
    Summary Antibe Therapeutics Inc (Antibe) is a biotechnology company that designs and develops drug candidates for chronic pain and inflammation; and regenerative medicine. The company discovers and commercialize novel drugs, biologics and medical devices. It offers lead compound ATB-346, a naproxen …
  • Bank of Jinzhou Co Ltd :企業の戦略・SWOT・財務情報
    Bank of Jinzhou Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank of Jinzhou Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • OsteoVantage Inc:製品パイプライン分析
    Summary OsteoVantage Inc (OsteoVantage) is a medical device company that develops osteogenic spinal instrumentation technology used in spinal fusion procedures. The company’s INDOS system is an osteogenic spinal instrumentation for use in lumbar spinal fusion procedures. It also offers osteomodulati …
  • Dev Information Technology Ltd (DEVIT):企業の財務・戦略的SWOT分析
    Dev Information Technology Ltd (DEVIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Jerusalem Insurance Company PLC:企業の戦略・SWOT・財務情報
    Jerusalem Insurance Company PLC - Strategy, SWOT and Corporate Finance Report Summary Jerusalem Insurance Company PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Thundelarra Ltd (THX):企業の財務・戦略的SWOT分析
    Summary Thundelarra Ltd (Thundelarra) is a mining and mineral exploration company. The company acquires, explores and develops lead, zinc, silver, nickel, graphite, copper, gold and uranium prospects in Western Australia and the Northern Territory. Its projects include Red Bore Copper-Gold Project, …
  • Getinge AB:戦略・SWOT・企業財務分析
    Getinge AB - Strategy, SWOT and Corporate Finance Report Summary Getinge AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Chimab SpA:企業の戦略・SWOT・財務情報
    Chimab SpA - Strategy, SWOT and Corporate Finance Report Summary Chimab SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Bell Food Group Ltd:戦略・SWOT・企業財務分析
    Bell Food Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Bell Food Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Prasco LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Prasco LLC (Prasco Laboratories) is a pharmaceutical company that manufactures and markets authorized generic and generic products. The company’s authorized generic products include acitretin capsules, clotrimazole and betamethasone dipropionate cream, atovaquone and proguanil HCl tablets, c …
  • Acorn Energy Inc (ACFN):企業の財務・戦略的SWOT分析
    Acorn Energy Inc (ACFN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆